Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 132
Filter
2.
J Gynecol Oncol ; 35(3): e90, 2024 May.
Article in English | MEDLINE | ID: mdl-38710527
4.
JMA J ; 7(1): 140-141, 2024 Jan 15.
Article in English | MEDLINE | ID: mdl-38314404
5.
Neurohospitalist ; 14(1): 112-113, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38235020
6.
Med Teach ; : 1, 2023 Dec 13.
Article in English | MEDLINE | ID: mdl-38092038
9.
10.
11.
PLoS One ; 17(10): e0275683, 2022.
Article in English | MEDLINE | ID: mdl-36264926

ABSTRACT

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders and affects approximately 4% of the global population. The diagnosis of IBS can be made based on symptoms using the validated Rome criteria and ruling out commonly occurring organic diseases. Although biomarkers exist for "IBS mimickers" such as celiac disease and inflammatory bowel disease (IBD), no such test exists for IBS. DNA microarrays of colonic tissue have been used to identify disease-associated variants in other gastrointestinal (GI) disorders. In this study, our objective was to identify biomarkers and unique gene expression patterns that may define the pathological state of IBS. Mucosal tissue samples were collected from the sigmoid colon of 29 participants (11 IBS and 18 healthy controls). DNA microarray analysis was used to assess gene expression profiling. Extraction and purification of RNA were then performed and used to synthesize cDNA. Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was employed to identify differentially expressed genes in patients diagnosed with IBS compared to healthy, non-IBS patient-derived cDNA. Additional testing probed vitamin D-mediated regulation of select genes associated with serotonergic metabolism. DNA microarray analyses led to the identification of 858 differentially expressed genes that may characterize the IBS pathological state. After screening a series of genes using a combination of gene ontological analysis and RT-qPCR, this spectrum of potential IBS biomarkers was narrowed to 23 genes, some of which are regulated by vitamin D. Seven putative IBS biomarkers, including genes involved in serotonin metabolism, were identified. This work further supports the hypothesis that IBS pathophysiology is evident within the human transcriptome and that vitamin D modulates differential expression of genes in IBS patients. This suggests that IBS pathophysiology may also involve vitamin D deficiency and/or an irregularity in serotonin metabolism.


Subject(s)
Irritable Bowel Syndrome , Humans , Biomarkers/metabolism , Diarrhea/pathology , DNA, Complementary/metabolism , Intestinal Mucosa/metabolism , Irritable Bowel Syndrome/diagnosis , Irritable Bowel Syndrome/genetics , Irritable Bowel Syndrome/complications , RNA/metabolism , RNA-Directed DNA Polymerase/metabolism , Serotonin/genetics , Serotonin/metabolism , Transcriptome , Tryptophan Hydroxylase/genetics , Vitamin D/metabolism , Vitamins/metabolism
12.
World J Gastrointest Surg ; 14(7): 727-730, 2022 Jul 27.
Article in English | MEDLINE | ID: mdl-36158282

ABSTRACT

Physical examination signs have not been well studied, and their accuracy and reliability in diagnosis remain unknown. The few studies available are limited in that the method of performing the sign was not stated, the technique used was not standardized, and the position of the appendix was not correlated with imaging or surgical findings. Some appendiceal signs were written in a non-English language and may not have been appropriately translated (e.g., Blumberg-Shchetkin and Rovsing). In other cases, the sign described differs from the original report (e.g., Rovsing, Blumberg-Shchetkin, and Cope sign, Murphy syndrome). Because of these studies limitations, gaps remain regarding the signs' utility in the bedside diagnosis of acute appendicitis. Based on the few studies available with these limitations in mind, the results suggest that a positive test is more likely to be found in acute appendicitis. However, a negative test does not exclude the diagnosis. Hence, these tests increase the likelihood of ruling in acute appendicitis when positive but are less helpful in ruling out disease when negative. Knowledge about the correct method of performing the sign may be a valuable adjunct to the surgeon in further increasing their pretest probability of disease. Furthermore, it may allow surgeons to study these signs further to better understand their role in clinical practice. In the interim, these signs should continue to be used as a tool to supplement the clinical diagnosis.

13.
J Family Med Prim Care ; 11(6): 3378-3379, 2022 Jun.
Article in English | MEDLINE | ID: mdl-36119188
14.
Cureus ; 14(2): e22164, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35308656

ABSTRACT

The clinical diagnosis of acute appendicitis is challenging as patients present with an array of objective and subjective symptoms early or late in the disease course. Ultrasound is routinely performed in all patients with suspected acute appendicitis. Equivocal test results frequently require further assessments using other imaging techniques that are limited in scope during pregnancy because of issues involving safety, availability, and accessibility. Physical examination diagnostic signs in acute appendicitis during pregnancy have not been well studied. Studies failed to describe, standardize, or correlate the technique used to the pathologic disease process. Therefore, gaps remain in current knowledge regarding the usefulness and application of these tests during the physical examination. Improvement in diagnostic acumen is critically important, particularly in cases where there remains diagnostic uncertainty because of equivocal imaging results. This article reviews signs used to diagnose patients with acute appendicitis using a pathophysiologic approach based on visceral and cerebrospinal nerve pathways to explain the mechanism for a positive test result. It also suggests a framework to study them further to better understand their role, if any, in clinical practice.

15.
J Med Biogr ; 30(2): 125-131, 2022 May.
Article in English | MEDLINE | ID: mdl-32924736

ABSTRACT

Born in 1884 in Balikesir, Turkey, Ömer Seyfettin was a leading figure among modern Turkish short story writers whose death in 1920 at the age of 36 led to long-term speculations about his fatal illness. In order to pay homage to his memory in the centennial of his death and to shed light on his later medical condition, this paper seeks to reexamine his last days from a medico-historical perspective. Our findings indicate that there was a notable decline in his health occurring after 1917 when he was confined to social isolation. A carbuncle was diagnosed in his posterior neck when he was 35-years of age and not satisfactorily treated. In late February 1920, he developed progressive symptoms over two weeks consisting initially of a headache, followed by fever, delirium, hallucinations, and diplopia. These clinical signs and symptoms are clinically suggestive of a septic encephalopathy presumably caused by staphylococcus aureus infection secondary to the carbuncle, or perhaps by one of the myriad causes of viral meningoencephalitis.

18.
Forensic Sci Med Pathol ; 18(1): 110-111, 2022 03.
Article in English | MEDLINE | ID: mdl-34449014
SELECTION OF CITATIONS
SEARCH DETAIL
...